Neolys Diagnostics 

Enabling oncologists to reach a better cancer treatment outcome with radiotherapy precision medicine support

OWNER

gille devillers (See Profile)


Sector

Predictive medicine

Stage

Development, market readiness, clinical trial

Country

France and the UK (Cardiff)

7 patent families and secret algorithms are protecting Neolys' solutions

Neolys' products are based on robust clinical trial results together with deep understanding of the mechanism of actions

Neolys has developed simple, robust and cost effective product offering

Neolys' technology is based on a platform applicable to other domain than Radiotherapy: chemotherapy; pesticites...

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck

Under evaluation at least till: 25th of June

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar